JP2017528142A5 - - Google Patents

Download PDF

Info

Publication number
JP2017528142A5
JP2017528142A5 JP2017514421A JP2017514421A JP2017528142A5 JP 2017528142 A5 JP2017528142 A5 JP 2017528142A5 JP 2017514421 A JP2017514421 A JP 2017514421A JP 2017514421 A JP2017514421 A JP 2017514421A JP 2017528142 A5 JP2017528142 A5 JP 2017528142A5
Authority
JP
Japan
Prior art keywords
mammalian
scnt
embryo
oocyte
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017514421A
Other languages
English (en)
Japanese (ja)
Other versions
JP6841753B2 (ja
JP2017528142A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/050178 external-priority patent/WO2016044271A2/en
Publication of JP2017528142A publication Critical patent/JP2017528142A/ja
Publication of JP2017528142A5 publication Critical patent/JP2017528142A5/ja
Application granted granted Critical
Publication of JP6841753B2 publication Critical patent/JP6841753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017514421A 2014-09-15 2015-09-15 ヒストンｈ３−リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物 Active JP6841753B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462050308P 2014-09-15 2014-09-15
US62/050,308 2014-09-15
US201462053514P 2014-09-22 2014-09-22
US62/053,514 2014-09-22
PCT/US2015/050178 WO2016044271A2 (en) 2014-09-15 2015-09-15 Methods and compositions to increase somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021023834A Division JP7277494B2 (ja) 2014-09-15 2021-02-18 ヒストンｈ３－リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物

Publications (3)

Publication Number Publication Date
JP2017528142A JP2017528142A (ja) 2017-09-28
JP2017528142A5 true JP2017528142A5 (enExample) 2018-11-01
JP6841753B2 JP6841753B2 (ja) 2021-03-10

Family

ID=55534004

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017514421A Active JP6841753B2 (ja) 2014-09-15 2015-09-15 ヒストンｈ３−リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物
JP2021023834A Active JP7277494B2 (ja) 2014-09-15 2021-02-18 ヒストンｈ３－リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物
JP2023001284A Pending JP2023026679A (ja) 2014-09-15 2023-01-06 ヒストンｈ３－リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021023834A Active JP7277494B2 (ja) 2014-09-15 2021-02-18 ヒストンｈ３－リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物
JP2023001284A Pending JP2023026679A (ja) 2014-09-15 2023-01-06 ヒストンｈ３－リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物

Country Status (5)

Country Link
US (3) US11390885B2 (enExample)
EP (1) EP3194581A4 (enExample)
JP (3) JP6841753B2 (enExample)
KR (2) KR102473092B1 (enExample)
WO (1) WO2016044271A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102473092B1 (ko) 2014-09-15 2022-12-01 칠드런'즈 메디컬 센터 코포레이션 히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
CN106591374B (zh) * 2016-12-30 2019-08-09 中国农业科学院北京畜牧兽医研究所 一种提高猪体细胞核移植胚胎发育效率的方法
CN106676136B (zh) * 2016-12-30 2019-11-29 中国农业科学院北京畜牧兽医研究所 一种提高猪体细胞核移植效率的方法
CN107299113A (zh) * 2017-06-12 2017-10-27 内蒙古大学 H3K27me3及其去甲基化酶KDM6A/B在小鼠核移植重构胚中的应用方法
CN108285906B (zh) * 2017-12-29 2021-07-09 温氏食品集团股份有限公司 一种定点整合外源dna转基因猪的构建方法
CN108624621B (zh) * 2018-01-17 2019-04-12 中国科学院上海生命科学研究院 非人灵长类的体细胞克隆动物的制备方法
CN117925511A (zh) * 2018-01-23 2024-04-26 车医科学大学校产学协力团 提高经体细胞复制的卵子的胚胎发育或胚胎形成的效率的方法
KR20190089782A (ko) * 2018-01-23 2019-07-31 차의과학대학교 산학협력단 멜라토닌을 포함하는, 배아 발달용 조성물 및 이를 이용하여 배아 발달의 효율을 향상시키는 방법
WO2019195738A1 (en) * 2018-04-06 2019-10-10 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
CN110547291A (zh) * 2019-09-27 2019-12-10 安徽医科大学 一种高效抗氧化的人卵母细胞冷冻保护剂
CN111466367B (zh) * 2020-02-17 2022-03-01 天津大学 用于保存细胞的组合物
KR102520268B1 (ko) * 2020-12-04 2023-04-12 대한민국 microRNA-148a 직접 주입을 통한 돼지 체세포 핵치환란의 발달율 향상 방법
CN113186152B (zh) * 2021-05-19 2023-05-26 南方医科大学 Dna甲基转移酶抑制剂在提高动物圆形精子注射胚胎发育效率中的应用
CN119162252B (zh) * 2024-11-20 2025-05-02 中国科学院昆明动物研究所 一种通过重构核移植囊胚提高克隆小鼠出生率的方法

Family Cites Families (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5023243A (en) 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US4441972A (en) 1983-04-08 1984-04-10 D.E.P. Systems, Inc. Apparatus for electrofusion of biological particles
US4664097A (en) 1984-05-09 1987-05-12 The Wistar Institute Of Anatomy & Biology Nuclear transplantation in the mammalian embryo by microsurgery and cell fusion
US4578168A (en) 1984-07-27 1986-03-25 Biotronics Apparatus for fusing live cells with electric fields
IL73883A (en) 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
JP2528107B2 (ja) 1985-03-15 1996-08-28 サマ−トン，ジエ−ムス ポリヌクレオチド測定試薬と方法
JPS6276624A (ja) * 1985-09-30 1987-04-08 Toshiba Corp レジスト剥離装置
US4994384A (en) 1986-12-31 1991-02-19 W. R. Grace & Co.-Conn. Multiplying bovine embryos
US5057420A (en) 1987-06-05 1991-10-15 Granada Biosciences, Inc. Bovine nuclear transplantation
US5213979A (en) 1987-12-30 1993-05-25 W. R. Grace & Co.-Conn. In vitro culture of bovine embryos
EP0435928A1 (en) 1988-09-21 1991-07-10 Animal Biotechnology Cambridge Limited Derivation of pluripotential embryonic cell lines from domestic animals
US4944384A (en) 1989-01-30 1990-07-31 Hay & Forage Industries Trash discharge apparatus for crop transferring conveyor mechanism
US5256775A (en) 1989-06-05 1993-10-26 Gilead Sciences, Inc. Exonuclease-resistant oligonucleotides
US5580774A (en) 1989-07-31 1996-12-03 Eli Lilly And Company Chimeric antibodies directed against a human glycoprotein antigen
US5264564A (en) 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
DE69034150T2 (de) 1989-10-24 2005-08-25 Isis Pharmaceuticals, Inc., Carlsbad 2'-Modifizierte Oligonukleotide
US5264562A (en) 1989-10-24 1993-11-23 Gilead Sciences, Inc. Oligonucleotide analogs with novel linkages
EP0452484B2 (en) 1989-11-06 2004-07-28 Cell Genesys, Inc. Production of proteins using homologous recombination
US5177198A (en) 1989-11-30 1993-01-05 University Of N.C. At Chapel Hill Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
US5223168A (en) 1989-12-12 1993-06-29 Gary Holt Surface cleaner and treatment
US5130302A (en) 1989-12-20 1992-07-14 Boron Bilogicals, Inc. Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
ATE156189T1 (de) 1989-12-22 1997-08-15 Applied Research Systems Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5587470A (en) 1990-01-11 1996-12-24 Isis Pharmaceuticals, Inc. 3-deazapurines
US5459255A (en) 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
US5506351A (en) 1992-07-23 1996-04-09 Isis Pharmaceuticals Process for the preparation of 2'-O-alkyl guanosine and related compounds
US5212295A (en) 1990-01-11 1993-05-18 Isis Pharmaceuticals Monomers for preparation of oligonucleotides having chiral phosphorus linkages
US5587361A (en) 1991-10-15 1996-12-24 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US5457191A (en) 1990-01-11 1995-10-10 Isis Pharmaceuticals, Inc. 3-deazapurines
US5578718A (en) 1990-01-11 1996-11-26 Isis Pharmaceuticals, Inc. Thiol-derivatized nucleosides
US5149797A (en) 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
CA2086330A1 (en) 1990-07-09 1992-01-10 Richard C. Fry Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor
US5096822A (en) 1990-07-26 1992-03-17 W. R. Grace & Co.- Conn. Bovine embryo medium
US5223618A (en) 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5608046A (en) 1990-07-27 1997-03-04 Isis Pharmaceuticals, Inc. Conjugated 4'-desmethyl nucleoside analog compounds
US5138045A (en) 1990-07-27 1992-08-11 Isis Pharmaceuticals Polyamine conjugated oligonucleotides
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
JPH0874B2 (ja) 1990-07-27 1996-01-10 アイシス・ファーマシューティカルス・インコーポレーテッド 遺伝子発現を検出および変調するヌクレアーゼ耐性、ピリミジン修飾オリゴヌクレオチド
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5218105A (en) 1990-07-27 1993-06-08 Isis Pharmaceuticals Polyamine conjugated oligonucleotides
US5623070A (en) 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5541307A (en) 1990-07-27 1996-07-30 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs and solid phase synthesis thereof
US5489677A (en) 1990-07-27 1996-02-06 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
US6262241B1 (en) 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
US5177196A (en) 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
JP3104995B2 (ja) 1991-01-31 2000-10-30 ワーナー−ランバート・コンパニー 抗炎症剤として有用な４，６−ジ−第三ブチル−５−ヒドロキシ−１，３−ピリミジンの置換されたヘテロアリール類似体
US5672697A (en) 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
EP1681305A3 (en) 1991-03-18 2008-02-27 New York University Monoclonal and chimeric antibodies specific for human tumor necrosis factor
EP0539573A4 (en) 1991-05-15 1993-12-29 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5173158A (en) 1991-07-22 1992-12-22 Schmukler Robert E Apparatus and methods for electroporation and electrofusion
US5599797A (en) 1991-10-15 1997-02-04 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
PT101031B (pt) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US5484908A (en) 1991-11-26 1996-01-16 Gilead Sciences, Inc. Oligonucleotides containing 5-propynyl pyrimidines
US5359044A (en) 1991-12-13 1994-10-25 Isis Pharmaceuticals Cyclobutyl oligonucleotide surrogates
JPH07509133A (ja) 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
US6107543A (en) 1992-08-20 2000-08-22 Infigen, Inc. Culture of totipotent embryonic inner cells mass cells and production of bovine animals
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5476925A (en) 1993-02-01 1995-12-19 Northwestern University Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
US5858988A (en) 1993-02-24 1999-01-12 Wang; Jui H. Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use
GB9304620D0 (en) 1993-03-06 1993-04-21 Ciba Geigy Ag Compounds
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5571902A (en) 1993-07-29 1996-11-05 Isis Pharmaceuticals, Inc. Synthesis of oligonucleotides
US5519134A (en) 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5554746A (en) 1994-05-16 1996-09-10 Isis Pharmaceuticals, Inc. Lactam nucleic acids
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5705629A (en) 1995-10-20 1998-01-06 Hybridon, Inc. Methods for H-phosphonate synthesis of mono- and oligonucleotides
JPH09260337A (ja) * 1996-03-26 1997-10-03 Nikon Corp 薄膜構造体の製造装置
US5994619A (en) 1996-04-01 1999-11-30 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Production of chimeric bovine or porcine animals using cultured inner cell mass cells
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
US6566131B1 (en) 2000-10-04 2003-05-20 Isis Pharmaceuticals, Inc. Antisense modulation of Smad6 expression
JP2995179B1 (ja) * 1998-07-31 1999-12-27 茂徳科技股▲ふん▼有限公司 浸漬液恒温供給システム
US6410323B1 (en) 1999-08-31 2002-06-25 Isis Pharmaceuticals, Inc. Antisense modulation of human Rho family gene expression
US6107091A (en) 1998-12-03 2000-08-22 Isis Pharmaceuticals Inc. Antisense inhibition of G-alpha-16 expression
US5981732A (en) 1998-12-04 1999-11-09 Isis Pharmaceuticals Inc. Antisense modulation of G-alpha-13 expression
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US6046321A (en) 1999-04-09 2000-04-04 Isis Pharmaceuticals Inc. Antisense modulation of G-alpha-i1 expression
JP2003526367A (ja) 2000-03-16 2003-09-09 ジェネティカ インコーポレイテッド Ｒｎａ干渉の方法とｒｎａ干渉組成物
KR20080023768A (ko) 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체
US6365354B1 (en) 2000-07-31 2002-04-02 Isis Pharmaceuticals, Inc. Antisense modulation of lysophospholipase I expression
US6566135B1 (en) 2000-10-04 2003-05-20 Isis Pharmaceuticals, Inc. Antisense modulation of caspase 6 expression
KR100909681B1 (ko) 2000-12-01 2009-07-29 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
US7612250B2 (en) 2002-07-29 2009-11-03 Trustees Of Tufts College Nuclear transfer embryo formation method
CA2501415A1 (en) 2002-08-01 2004-02-12 Gtc Biotherapeutics, Inc. Method of selecting cells for somatic cell nuclear transfer
US20040148648A1 (en) 2002-12-10 2004-07-29 Esmail Behboodi Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer
EP1615492A4 (en) 2003-04-09 2010-07-14 Magee Womens Health Corp METHOD FOR CORRECTING MITOSE SPINDLE DEFECTS IN SOMATIC CELL CORE TRANSFER IN ANIMALS
US8807129B2 (en) 2004-08-10 2014-08-19 Kevin Keith Mackamul Tracker drive system and solar energy collection system
AU2005304978A1 (en) 2004-11-04 2006-05-18 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
WO2006116803A1 (en) * 2005-04-29 2006-11-09 Innovative Dairy Products Pty Ltd As Trustee For The Participants Of The Cooperative Research Centre For Innovative Dairy Products A method for producing stem cells or stem cell-like cells from mammalian embryos
ES2937245T3 (es) 2005-08-23 2023-03-27 Univ Pennsylvania ARN que contiene nucleósidos modificados y métodos de uso del mismo
JP2007117081A (ja) 2005-09-30 2007-05-17 Institute Of Physical & Chemical Research 核移植卵子の作製方法
CA2597840A1 (en) 2006-09-01 2008-03-01 Government Of The United States Of America, As Represented By The Secret Ary, Department Of Health And Human Services Methods and compositions for the treatment and prevention of cancer
CN101514878B (zh) * 2008-02-18 2010-09-29 扬博科技股份有限公司 用于基板制程的热交换系统
US20110172107A1 (en) 2008-04-30 2011-07-14 Fox Chase Cancer Center Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby
US20110136145A1 (en) 2008-05-22 2011-06-09 The Johns Hopkins University Methods for promoting fusion and reprogramming of somatic cells
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
DE102009039097B3 (de) 2009-08-27 2010-11-25 Siemens Aktiengesellschaft Verfahren zum Übertragen von Daten in einem Sensornetzwerk, Sensorknoten und Zentral-Rechner
WO2011082038A2 (en) 2009-12-31 2011-07-07 Fate Therapeutics, Inc. Improved reprogramming compositions
CA2796464C (en) 2010-04-16 2021-08-03 Immune Disease Institute, Inc. Sustained polypeptide expression from synthetic, modified rnas and uses thereof
US8315599B2 (en) 2010-07-09 2012-11-20 Telecommunication Systems, Inc. Location privacy selector
CN201768705U (zh) * 2010-08-18 2011-03-23 州巧科技股份有限公司 节能清洗系统
JP5934213B2 (ja) 2010-08-25 2016-06-15 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー 無線電源システム及び多層シムアセンブリ
WO2012029957A1 (ja) 2010-09-03 2012-03-08 独立行政法人理化学研究所 クローン動物の作出方法
KR101290029B1 (ko) 2011-01-20 2013-07-30 에스티팜 주식회사 시타글립틴의 중간체 제조방법
EP2714903B1 (en) 2011-06-03 2018-03-21 OncoTherapy Science, Inc. Suv39h2 as a target gene for cancer therapy
WO2013050405A1 (en) 2011-10-03 2013-04-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of th2 mediated diseases
US20140161785A1 (en) 2012-12-10 2014-06-12 Feiyan Liu Verticillin A Inhibition of Histone Methyltransferases
AU2014217550B2 (en) 2013-02-15 2017-09-07 Sung Kwang Medical Foundation Production of parthenogenetic stem cells and patient-specific human embryonic stem cells using somatic cell nuclear transfer
US20160113911A1 (en) 2013-06-06 2016-04-28 The General Hospital Corporation Methods and compositions for the treatment of cancer
KR102473092B1 (ko) 2014-09-15 2022-12-01 칠드런'즈 메디컬 센터 코포레이션 히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
JP2018530349A (ja) 2015-10-09 2018-10-18 チルドレンズ メディカル センター コーポレーション ヒストンｈ３−リシントリメチル化の排除によりヒト体細胞核移入（ｓｃｎｔ）の効率を増加する方法および組成物、ならびにヒトｎｔ−ｅｓｃの誘導方法
WO2018073787A2 (en) 2016-10-19 2018-04-26 Fred Hutchinson Cancer Research Center Compositions and methods for reprogramming cells and for somatic cell nuclear transfer using duxc expression
CN107299113A (zh) 2017-06-12 2017-10-27 内蒙古大学 H3K27me3及其去甲基化酶KDM6A/B在小鼠核移植重构胚中的应用方法
CN111132671B (zh) 2017-07-19 2023-10-27 儿童医疗中心有限公司 治疗印记缺陷相关疾病的组合物和方法
WO2019195738A1 (en) 2018-04-06 2019-10-10 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
US20210292793A1 (en) 2018-07-19 2021-09-23 Children's Medical Center Corporation Compositions and methods for generating physiological x chromosome inactivation
JP3224832U (ja) * 2019-11-06 2020-01-23 揚▲博▼科技股▲分▼有限公司 基板エッチング処理装置における制御ボックスの散熱装置
JP7631092B2 (ja) * 2021-05-19 2025-02-18 株式会社Ｓｃｒｅｅｎホールディングス 基板処理システム

Similar Documents

Publication Publication Date Title
JP2017528142A5 (enExample)
JP2018530349A5 (enExample)
Wani et al. First cloned Bactrian camel (Camelus bactrianus) calf produced by interspecies somatic cell nuclear transfer: A step towards preserving the critically endangered wild Bactrian camels
CN105934512A (zh) 用于在核基因转移的受体中产生没有发育能力的卵子的方法和组合物
Fujihara et al. Production of mouse pups from germline transmission-failed knockout chimeras
CN118652837A (zh) 稳定的多能牛胚胎干细胞的高效衍生
Latham Cloning: questions answered and unsolved
Lee et al. Comparative study of the developmental competence of cloned pig embryos derived from spermatogonial stem cells and fetal fibroblasts
Priya et al. Production of wild buffalo (Bubalus arnee) embryos by interspecies somatic cell nuclear transfer using domestic buffalo (Bubalus bubalis) oocytes
CN112272516B (zh) 用于体细胞重新编程和调整印记的组合物和方法
Latham Preimplantation embryo gene expression: 56 years of discovery, and counting
JP2024102048A (ja) Ｒａｄ５１活性化剤を含む胚発達用組成物、及びそれを利用して胚発達率を向上させる方法
CN109837307B (zh) 建立含外源染色体的胚胎干细胞的方法
KR20160084431A (ko) 유전자 변형 동물을 생산하기 위한 조성물 및 방법
Zhang et al. Effects of histone deacetylase inhibitors on the early development of bovine androgenetic embryos
Wittayarat et al. Histone deacetylase inhibitor improves the development and acetylation levels of cat–cow interspecies cloned embryos
Mrowiec et al. Technical, biological and molecular aspects of somatic cell nuclear transfer–a review
Loi et al. Cloning the mammoth: a complicated task or just a dream?
Morovic et al. Mouse oocytes nucleoli rescue embryonic development of porcine enucleolated oocytes
Hu et al. Analysis of imprinted gene expression and implantation in haploid androgenetic mouse embryos
CN1794908B (zh) 通过核移植克隆大鼠的方法
Popova et al. Full-term development of rat after transfer of nuclei from two-cell stage embryos
Venegas et al. Obtaiment of Pudu (Pudu pudu) deer embryos by the somatic nuclear transfer technique
Yao et al. Ooplast transfer of triploid pronucleus zygote improve reconstructed human-goat embryonic development
US20250388858A1 (en) Composition for embryonic development, comprising rad51 activator, and method for improving embryonic development rate using same